Affiliation:
1. Guangdong Women and Children Hospital
Abstract
Abstract
Background: At present, the usual methods used to detect a-thalassemia mutations are confined to detect the common mutations, which may easy to result in misdiagnosis or missed diagnosis. Single molecule real time sequencing (SMRT) enables long-read single-molecule sequencing with high detection accuracy, and long-length DNA chain reads in high-fidelity reads mode.
Methods: Herein, we used SMRT to detect rare and complex variants in a-globin locus in four individuals whose hematological data indicated microcytic hypochromic anemia but conventional thalassemia detecting result was negative. Multiplex ligation-dependent probe amplification (MLPA) and droplet digital polymerase chain reaction (ddPCR) were used to confirm the results of SMRT.
Results: We found 4 novel large deletions ranging from 23 kb to 81 kb in a-globin locus, among which one patient also has a duplication inserted in the deletional fragment. In addition, one patient with 27.31 kb deletion on chromosome 16 (hg 38) was also detected to be abnormal hemoglobin Siriraj (Hb Siriraj).
Conclusion: We first identified the four novel deletions in a-globin locus by using SMRT. Given that conventional methods may lead to misdiagnosis or missed diagnosis, SMRT served as a good method to discover rare and complex variants in thalassemia, especially in prenatal diagnosis.
Publisher
Research Square Platform LLC
Reference15 articles.
1. The molecular basis of alpha-thalassemia: a model for understanding human molecular genetics;Higgs DR;Hematol Oncol Clin North Am,2010
2. The prevalence and molecular spectrum of alpha- and beta-globin gene mutations in 14,332 families of Guangdong Province, China;Yin A;Plos One,2014
3. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China;Xiong F;Clin Genet,2010
4. Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies;Shang X;EBioMedicine,2017
5. Cappellini MD, Farmakis D, Porter J, Taher A. (2021). Guidelines for the Management of Transfusion Dependence Thalassemia (TDT), 4th Edition. Nicosia, Cyprus: Thalassemia International Federation.